Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
Open Access
- 1 January 2018
- journal article
- research article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 51 (12), 630-635
- https://doi.org/10.5483/BMBRep.2018.51.12.140
Abstract
C-X-C motif chemokine ligand 2 (CXCL2) is a small secreted protein that exhibits a structure similar to the proangiogenic subgroup of the CXC chemokine family. Recently, accumulating evidence suggests that chemokines play a pivotal role in cancer progression and carcinogenesis. We examined the expression levels of 7 types of ELR+ CXCLs messenger RNA (mRNA) in 264 clinical samples. We found that CXCL2 expression was stably down-regulated in 94% of hepatocellular carcinoma (HCC) specimens compared with paired adjacent normal liver tissues and some HCC cell lines. Moreover, CXCL2 overexpression profoundly attenuated HCC cell proliferation and growth and induced apoptosis in vitro. In animal studies, we found that overexpressing CXCL2 by lentivirus also apparently inhibited the size and weight of subcutaneous tumours in nude mice. Furthermore, we demonstrated that CXCL2 induced HCC cell apoptosis via both nuclear and mitochondrial apoptosis pathways. Our results indicate that CXCL2 negatively regulates the cell cycle in HCC cells via the ERK1/2 signalling pathway. These results provide new insights into HCC and may ultimately lead to the discovery of innovative therapeutic approaches of HCC.Keywords
Funding Information
- National Natural Science Foundation of China (no.81721091, no.91542205)
- Chinese Academy of Medical Sciences (no.2017PT32006)
- Natural Science Foundation of Zhejiang Province (no.Y15H160054, no.LY15H160017)
This publication has 32 references indexed in Scilit:
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Cancer-related inflammationNature, 2008
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Cytokines in cancer immunity and immunotherapyImmunological Reviews, 2004
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinaseNature, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Universal control mechanism regulating onset of M-phaseNature, 1990
- Under arrest in the cell cycleNature, 1989